 Stockopedia |
Abcam – the next giant of the Life Sciences?
Stockopedia But in spite of this, Jonathan Milner believes the opportunities available to Abcam are huge and has the dream of building the company into a giant of the life sciences. With the valuation now reaching a PE ratio of 27 times forecast earnings, … |
Go here to see the original:
Abcam – the next giant of the Life Sciences? – Stockopedia
Thu, Apr 7, 2011
Body Building Health